Redox-Active Natural Compounds in Metabolic and Inflammatory Diseases: Pharmacological Potential and Limitations
This special issue belongs to the section "Natural Products".
Special Issue Information
Dear Colleagues,
Redox-active natural compounds have attracted increasing interest as potential pharmacological agents in the prevention and treatment of metabolic and inflammatory diseases. Numerous plant-derived polyphenols, flavonoids, terpenoids, and other bioactive molecules exhibit antioxidant, anti-inflammatory, and cytoprotective properties; however, their mechanisms of action, bioavailability, pharmacokinetics, and clinical relevance remain incompletely understood. Importantly, growing evidence suggests that these compounds do not act merely as direct antioxidants, but rather as modulators of redox-sensitive signaling pathways, mitochondrial function, and inflammatory cascades.
This Special Issue aims to provide a critical and mechanistic perspective on the pharmacological potential of redox-active natural compounds in metabolic and inflammatory disorders, including obesity, diabetes, metabolic syndrome, and renal and respiratory diseases. Particular emphasis will be placed on molecular targets, dose–response relationships, translational relevance, and limitations of current experimental and clinical evidence. We welcome original research articles and high-quality reviews addressing both beneficial and adverse effects, interactions with conventional pharmacotherapy, and challenges related to standardization and reproducibility.
By integrating basic, preclinical, and clinical research, this Special Issue seeks to move beyond descriptive antioxidant claims and identify realistic therapeutic opportunities and constraints for natural redox-active compounds in modern pharmacology.
Dr. Mateusz Mołoń
Dr. Sabina Galiniak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- redox-active natural compounds
- oxidative stress modulation
- metabolic diseases
- inflammation
- antioxidant pharmacology
- bioactive phytochemicals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

